Benitec Biopharma Inc. (BNTC)
Nasdaq: BNTC · Pharmaceutical Preparations · Hayward, CA · filing with the SEC since 2020
Who runs Benitec Biopharma Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Banks Jerel A.
Chief Executive Officer. First filing Apr 2020, latest Nov 20, 2025, 0 filings in all.
Officers reporting now
3
of 13 people with a filing in the last fifteen months
Directors reporting now
10
13 people on the record since 2020
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Banks Jerel A. | Chief Executive Officer | Apr 2020 | Nov 20, 2025 | none |
| Boston Megan | Chief Financial Officer | Apr 2020 | Nov 20, 2025 | none |
| Mukadam Sophie | Chief Operating Officer | Jan 2025 | Nov 20, 2025 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Buchi J Kevin | director | Apr 2020 | Jun 30, 2026 | none |
| Friedman David Matthew | director | May 2026 | May 28, 2026 | none |
| Mates Sharon | director | Nov 2025 | Jan 26, 2026 | none |
| Averill Madison Master Fund, Ltd. | director | May 2024 | Dec 29, 2025 | none |
| Averill Master Fund, Ltd. | director | May 2024 | Dec 29, 2025 | none |
| Cowen Aaron | director | May 2024 | Dec 29, 2025 | none |
| Suvretta Capital Management, LLC | director | May 2024 | Dec 29, 2025 | none |
| Francis Peter | director | Apr 2020 | Dec 3, 2025 | none |
| Mehta Kishan | director | Jul 2024 | Dec 3, 2025 | none |
| Smith Edward F | director | Apr 2020 | Dec 3, 2025 | none |
Earlier names on the record4, newest filing first
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.